You are here

Ian Read, Chairman and CEO of Pfizer, discusses a potential combination with AstraZeneca

Ian Read AstraZeneca Announcement


Question 1 – Why is Pfizer interested in a combination with AstraZeneca? Why AstraZeneca? What are the main benefits for shareholders and other stakeholders?


Question 2 - What is the motivation for the potential combination?


Question 3 How would you accomplish a large scale integration, should you be successful?


Question 4 Is Pfizer truly committed to R&D and what is your commitment to Cambridge, UK?